2,180 matches for your search in the start-up spotlight
rss
Swiss Vascular leads the development of patient-specific high-precision 3D vascular models, facilitating advancements in pre-surgical planning, medical training, and device development. Our cutting-edge models are meticulously crafted by using state-of-the-art additive manufacturing techniques ...
SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. The Company’s lead program, SB-007, targets the root cause of Stargardt disease, a genetic eye disease that causes blindness in children and adults. ...
DYPHOX stands for innovation! We offer: - Development, manufacture and marketing of products for equipping material surfaces, liquids or solids with photocatalytic properties - Development, production and marketing of specialty chemicals and intermediates, especially for oxidation processes - ...
We are Europe's fastest-growing fusion startup, building the first generation of fusion power plants using quasi-isodynamic (QI) stellarators—the clearest, most robust path to putting fusion on the grid.
We are a spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy. Fusix Biotech GmbH is a Munich based start-up founded in 2022. The management team is comprised of the four ...
Visienco is a Swiss techbio company on a mission to make organoids clinically reliable at scale. Organoids, lab-grown mini-organs, are transforming how we understand human biology and test therapies. But their full potential is limited by manual, variable, and low-throughput workflows. At ...
For growers who want to get the best yield without wasting resources, NutriSen has developed the first biosensors test strips that can measure the amount of nitrate in plants directly in the field. Instead of indirect measurements such as chlorophyll content, NutriSen provides lab-accurate ...
The TQx platform will transform the traditional way of producing cellular therapies, which is often slow, expensive, and hard to scale, into a very fast and highly automated process right at the patient's side. This method uses extra-corporeal gene therapy but keeps the benefits of autologous ...
ReproNovo was founded in 2021 by a team with proven expertise in the reproductive medicine and women’s health space. With years of immersion in this field, we possess deep knowledge of drug development, regulatory affairs and business development in these therapeutic areas, the treatment ...
Our mission: We revolutionise protein diagnostics. As top researchers in the field of protein science, we pursue the goal of detecting neurodegenerative diseases at an early stage in order to prevent their progression to symptomatic conditions.
